Hovid Berhad

Hovid Berhad is a leading Malaysian pharmaceutical company specializing in the manufacture of over-the-counter generics, prescription drugs, dietary supplements, and consumer healthcare products. The company has more than four decades of experience since its transformation from a traditional herbal tea business. It operates globally with over 400 marketed products across more than fifty countries. Its R&D focus includes innovative drug delivery systems—such as Suprabio® tocotrienol—and it runs one of Malaysia's largest BE centers to ensure product quality through bioequivalence studies. Notably, its proprietary tocotrienol formulation "Tocovit Superbio" has reached Phase II clinical trials in the US targeting neurodegenerative diseases and end-stage liver disease.